Achillion Says Hepatitis Studies Show Strong Results

Achillion Pharmaceuticals said that a regimen intended to treat hepatitis C patients showed strong results amid an increasingly competitive market for drugs to fight the disease



from WSJ.com: US Business http://ift.tt/13wDiW9

via IFTTT